Quantitative -omic data empowers bottom-up systems biology

https://doi.org/10.1016/j.copbio.2018.01.009Get rights and content

Highlights

  • Simple systems are the best starting points for the application of systems biology.

  • New experimental technologies allow for the generation of quantitative -omic data.

  • Computational methods are being developed to incorporate quantitative data.

  • Quantitative -omic data are bringing us closer to next-generation whole-cell models.

The large-scale generation of ‘-omic’ data holds the potential to increase and deepen our understanding of biological phenomena, but the ability to synthesize information and extract knowledge from these data sets still represents a significant challenge. Bottom-up systems biology overcomes this hurdle through the integration of disparate -omic data types, and absolutely quantified experimental measurements allow for direct integration into quantitative, mechanistic models. The human red blood cell has served as a starting point for the application of systems biology approaches and has been the focus of a recent burst of generated quantitative metabolomics and proteomics data. Thus, the red blood cell represents the perfect case study through which to examine our ability to glean knowledge from the integration of multiple disparate data types.

Introduction

Over the last two decades, the life sciences have witnessed a paradigm shift brought on by the development of high-throughput ‘-omic’ technologies. With the advent of these technologies, systems biology emerged as a way to holistically integrate the new data being generated. Integrative thinking was not something previously absent in molecular biology, it was just that high-throughput -omic technologies were making the scale of these integrative inquiries much larger [1]. With the availability of full genome sequences and other data, more and more researchers embraced the promise in systems biology and began to develop ways to bridge the gap between -omic data and computational modeling efforts [2].

Some of the first cell-scale computational models were published in the late 1980s [3]. These enzyme kinetic models detailed the known metabolic network of the human red blood cell (RBC). Why study the RBC? The reasoning was simple: if systems biology cannot be successfully applied to the simplest human cell, then why attempt to study more complex ones? Indeed, simple systems are the best starting point for the application of systems biology. The RBC is therefore a logical starting point for the development and application of systems biology methods because of its simplicity and intrinsic experimental accessibility. RBCs are also of great importance for our understanding of human health and physiology  over 84% of all human cells by count are RBCs [4]. Transfusion medicine represents an integral part of healthcare, with approximately 85 million RBC units transfused worldwide annually [5]. The systems biology analysis of the health of stored RBCs is thus a productive focus from a basic and applied standpoint.

Within the last several years, -omic technologies have been exploited to study RBCs under refrigerated storage for use in transfusion medicine [6•, 7•] in an attempt to understand and elucidate the underlying physiological changes that occur because of the artificial environment [8]. Concurrently, computational biologists have worked to develop new mathematical modeling frameworks that can use these data. Because of the inherent quantitative nature of these models, however, their utility is only fully realized with quantitative data. In this context, quantitative data implies the use of standards to absolutely quantify the abundance of measured species; the output is data with quantified units (e.g., g/L, mM), rather than qualitative data that have relative units (e.g., arbitrary units, relative signal). While there have been several important studies that have used qualitative data effectively, the future of systems biology modeling efforts will hinge upon the availability of high quality quantitative data.

In this article, we discuss some of the recent work in -omic data generation and corresponding computational methodologies. In particular, we focus on how the use of quantitative data aids modeling efforts and enables new questions to be asked. We review studies on a variety of organisms, using the RBC as a case study throughout. We first discuss -omic data types and new experimental techniques that will likely prove to be valuable for the field; we then survey a variety of computational modeling approaches that integrate these data types and review important advances to date; finally, we close with perspectives on where the field of systems biology is with respect to the integration of -omic data and what the next steps might be.

Section snippets

A variety of -omic data types describe cellular physiology

A cell is a system of interconnected complex systems described by a variety of -omic data types [9••]. Metabolomics data provide a snapshot of the cellular biochemistry that details energy production [10]. Fluxomics measurements  the use of isotopic tracers (e.g. 13C)  yield an understanding of the flux state of a metabolic network [11]. Proteomics data allow for an understanding of the abundance, localization, and interactions of proteins, the cellular machinery underlying all metabolic

Perspectives

As we have discussed, there are many quantitative -omic data sets available for a variety of organisms and cell types. Such data will undoubtedly enable a new wave of systems biology models. However, it is not enough to simply generate quantitative data; the data itself must also be high quality. High quality data means generating an appropriate number of replicates to capture inherent biological variability, account for the batch effect, and provide statistical power. Any model, whether based

Conflict of interest statement

The authors declare no competing financial interests.

References and recommended reading

Papers of particular interest, published within the period of review, have been highlighted as:

  • • of special interest

  • •• of outstanding interest

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Due to restrictions on the number of references and our inability to survey the entire bibliome, several important studies were omitted.

References (81)

  • G. Liebisch et al.

    Reporting of lipidomics data should be standardized

    Biochim Biophys Acta

    (2017)
  • K. Yang et al.

    Lipidomics: techniques, applications, and outcomes related to biomedical sciences

    Trends Biochem Sci

    (2016)
  • L. Geris et al.

    Uncertainty in Biology: A Computational Modeling Approach

    (2015)
  • S.M. Hanson et al.

    Modeling error in experimental assays using the bootstrap principle: understanding discrepancies between assays using different dispensing technologies

    J Comput Aided Mol Des

    (2015)
  • A. Bordbar

    Interpreting the deluge of omics data: new approaches offer new possibilities

    Blood Transfus

    (2017)
  • K. Yizhak et al.

    Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model

    Bioinformatics

    (2010)
  • Q. Zhong et al.

    An inter-species protein–protein interaction network across vast evolutionary distance

    Mol Syst Biol

    (2016)
  • G.J.C.G.M. Bosman

    The proteome of the red blood cell: an auspicious source of new insights into membrane-centered regulation of homeostasis

    Proteomes

    (2016)
  • H.V. Westerhoff et al.

    The evolution of molecular biology into systems biology

    Nat Biotechnol

    (2004)
  • A. Joshi et al.

    Metabolic dynamics in the human red cell: Part I  A comprehensive kinetic model

    J Theor Biol

    (1989)
  • R. Sender et al.

    Revised estimates for the number of human and bacteria cells in the body

    PLoS Biol

    (2016)
  • M. García-Roa et al.

    Red blood cell storage time and transfusion: current practice, concerns and future perspectives

    Blood Transfus

    (2017)
  • T. Nemkov et al.

    Metabolomics in transfusion medicine

    Transfusion (Paris)

    (2016)
  • A. D’Alessandro et al.

    Omics markers of the red cell storage lesion and metabolic linkage

    Blood Transfus

    (2017)
  • A. D’Alessandro et al.

    Hitchhiker's guide to the red cell storage galaxy: omics technologies and the quality issue

    Transfus Apher Sci

    (2017)
  • J. Nielsen

    Systems biology of metabolism

    Annu Rev Biochem

    (2017)
  • N. Zamboni et al.

    Defining the metabolome: size, flux, and regulation

    Mol Cell

    (2015)
  • M. Larance et al.

    Multidimensional proteomics for cell biology

    Nat Rev Mol Cell Biol

    (2015)
  • X. Han

    Lipidomics for studying metabolism

    Nat Rev Endocrinol

    (2016)
  • G. Paglia et al.

    Biomarkers defining the metabolic age of red blood cells during cold storage

    Blood

    (2016)
  • G. Paglia et al.

    Metabolic fate of adenine in red blood cells during storage in SAGM solution

    Transfusion (Paris)

    (2016)
  • A. D’Alessandro et al.

    Metabolomics of AS-5 RBC supernatants following routine storage

    Vox Sang

    (2015)
  • A. D’Alessandro et al.

    Routine storage of red blood cell (RBC) units in additive solution-3: a comprehensive investigation of the RBC metabolome

    Transfusion (Paris)

    (2015)
  • A. D’Alessandro et al.

    Red blood cell storage in additive solution-7 preserves energy and redox metabolism: a metabolomics approach

    Transfusion (Paris)

    (2015)
  • J.D. Roback et al.

    Metabolomics of ADSOL (AS-1) red blood cell storage

    Transfus Med Rev

    (2014)
  • L.J. Dumont et al.

    CO2-dependent metabolic modulation in red blood cells stored under anaerobic conditions

    Transfusion (Paris)

    (2016)
  • A. D’Alessandro et al.

    Red blood cell metabolic responses to refrigerated storage, rejuvenation, and frozen storage

    Transfusion (Paris)

    (2017)
  • J. Krumsiek et al.

    Bayesian independent component analysis recovers pathway signatures from blood metabolomics data

    J Proteome Res

    (2012)
  • A. Bordbar et al.

    Identified metabolic signature for assessing red blood cell unit quality is associated with endothelial damage markers and clinical outcomes

    Transfusion (Paris)

    (2016)
  • Ó. Rolfsson et al.

    Mannose and fructose metabolism in red blood cells during cold storage in SAGM

    Transfusion (Paris)

    (2017)
  • Cited by (24)

    • A knowledge integration strategy for the selection of a robust multi-stress biomarkers panel for Bacillus subtilis

      2023, Synthetic and Systems Biotechnology
      Citation Excerpt :

      One of the goals of the biotechnology industry is to recognise these detrimental cellular states so that strategies for mitigating the damage can be engineered [5,6]. Detrimental states can be characterised and recognised using a variety of techniques, from morphological and biochemical assays [7,8] to omics methods [9]. In the context of omics methods, panels of genes whose expression are indicative of certain cellular states can be used as transcriptional biomarkers.

    • Model reduction of genome-scale metabolic models as a basis for targeted kinetic models

      2021, Metabolic Engineering
      Citation Excerpt :

      For these reasons kinetic models have yet not been fully integrated into the DBTL framework (St John and Bomble, 2019), despite smaller kinetic models having provided valuable understanding of metabolic systems. Still, recent advances in metabolomics and fluxomics have greatly increased the feasibility of the large-scale data collection that is required to parameterise dynamic metabolic models (Link et al., 2015; Park et al., 2016; Markley et al., 2017; Yurkovich and Palsson, 2018). Furthermore, more and more of these techniques are used to clarify the complex web of metabolic regulation that drives core metabolism (Gerosa et al., 2015; Hackett et al., 2016; Piazza et al., 2018).

    • The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia

      2020, Schizophrenia Research
      Citation Excerpt :

      In addition, another consortium, ProteomicsDB (https://www.ProteomicsDB.org), released in 2014, is a protein-centric in-memory database for the exploration of large collections of quantitative mass spectrometry-based proteomics data (Frejno et al., 2017). The ultimate goals of omics investigations are to discover pathophysiologic mechanisms and to form therapeutic strategies by incorporating multiple types and levels of information (Yugi et al., 2016; Yurkovich and Palsson, 2018). Considering its complex and heterogeneous nature, the pathophysiology of schizophrenia (Boyle et al., 2017; Fromer et al., 2016) will be delineated not by a single omics alone, e.g., genomics or transcriptomics (Geschwind and State, 2015; Prinz et al., 2004; Willsey and State, 2015) but by integration of multi-omics outcomes.

    • Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry

      2019, Journal of Pharmaceutical and Biomedical Analysis
      Citation Excerpt :

      Metabolomics approach has been proved to explore the biomarkers and mechanism of diabetic kidney disease. Quantitative metabolomics aims at preselected metabolites to seek the specific biomarkers to distinguish different states of biological system and then explore the disease pathogenesis [6]. Thus, based on gas chromatography coupled with mass spectrometry (GC–MS) and liquid chromatography tandem with mass spectrometry (LC–MS/MS), this study focused on producing a quantitative analysis of 25 fatty acids, 18 amino acids, 19 nucleosides and nucleobases in rat plasma induced by streptozotocin (STZ) to find biomarkers with relation to the occurrence and development of DN.

    View all citing articles on Scopus
    View full text